Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steffen Heeg

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Cancer Science|December 16, 2010
EGFR overexpression induces activation of telomerase via PI3K/AKT-mediated phosphorylation and transcriptional regulation through Hif1-alpha in a cellular model of oral-esophageal carcinogenesisSteffen Heeg, Nina Hirt, Angela Queisser, et al.
Genes & Development|January 29, 2013
The Prrx1 homeodomain transcription factor plays a central role in pancreatic regeneration and carcinogenesisMaximilian Reichert, Shigetsugu Takano, Johannes von Burstin, et al.
Gastroenterology|June 19, 2016
ETS-Transcription Factor ETV1 Regulates Stromal Expansion and Metastasis in Pancreatic CancerSteffen Heeg, Koushik K Das, Maximilian Reichert, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 22, 2005
Creating oral squamous cancer cells: a cellular model of oral-esophageal carcinogenesisGitta Goessel, Michael Quante, William C Hahn, et al.
Scandinavian Journal of Gastroenterology|October 15, 2019
Esophageal lichen planus: towards diagnosis of an underdiagnosed diseaseFranziska Schauer, Carmen Monasterio, Kristin Technau-Hafsi, et al.
Cancers|October 30, 2020
Efficacy and Safety of CAP7.1 as Second-Line Treatment for Advanced Biliary Tract Cancers: Data from a Randomised Phase II StudyUlrich-Frank Pape, Stefan Kasper, Johannes Meiler, et al.
Oncology Research and Treatment|September 9, 2024
Paclitaxel/Ramucirumab versus Paclitaxel in 2nd-Line Therapy of Advanced Esophageal Squamous Cell Carcinoma: Randomized Phase II IKF-AIO-RAMOS TrialMagdalena K Scheck, Thorsten O Goetze, Thomas J Ettrich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2023
Effect of Hyperthermic Intraperitoneal Chemotherapy on Cytoreductive Surgery in Gastric Cancer With Synchronous Peritoneal Metastases: The Phase III GASTRIPEC-I TrialBeate Rau, Hauke Lang, Alfred Koenigsrainer, et al.
Blood|June 17, 2020
Glucagon-like peptide 2 for intestinal stem cell and Paneth cell repair during graft-versus-host disease in mice and humansJohana Norona, Petya Apostolova, Dominik Schmidt, et al.
JCO Precision Oncology|September 11, 2020
Personalized Clinical Decision Making Through Implementation of a Molecular Tumor Board: A German Single-Center ExperienceRouven Hoefflin, Anna-Lena Geißler, Ralph Fritsch, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Cancer Science|December 16, 2010
EGFR overexpression induces activation of telomerase via PI3K/AKT-mediated phosphorylation and transcriptional regulation through Hif1-alpha in a cellular model of oral-esophageal carcinogenesisSteffen Heeg, Nina Hirt, Angela Queisser, et al.
Genes & Development|January 29, 2013
The Prrx1 homeodomain transcription factor plays a central role in pancreatic regeneration and carcinogenesisMaximilian Reichert, Shigetsugu Takano, Johannes von Burstin, et al.
Gastroenterology|June 19, 2016
ETS-Transcription Factor ETV1 Regulates Stromal Expansion and Metastasis in Pancreatic CancerSteffen Heeg, Koushik K Das, Maximilian Reichert, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 22, 2005
Creating oral squamous cancer cells: a cellular model of oral-esophageal carcinogenesisGitta Goessel, Michael Quante, William C Hahn, et al.
Scandinavian Journal of Gastroenterology|October 15, 2019
Esophageal lichen planus: towards diagnosis of an underdiagnosed diseaseFranziska Schauer, Carmen Monasterio, Kristin Technau-Hafsi, et al.
Cancers|October 30, 2020
Efficacy and Safety of CAP7.1 as Second-Line Treatment for Advanced Biliary Tract Cancers: Data from a Randomised Phase II StudyUlrich-Frank Pape, Stefan Kasper, Johannes Meiler, et al.
Oncology Research and Treatment|September 9, 2024
Paclitaxel/Ramucirumab versus Paclitaxel in 2nd-Line Therapy of Advanced Esophageal Squamous Cell Carcinoma: Randomized Phase II IKF-AIO-RAMOS TrialMagdalena K Scheck, Thorsten O Goetze, Thomas J Ettrich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2023
Effect of Hyperthermic Intraperitoneal Chemotherapy on Cytoreductive Surgery in Gastric Cancer With Synchronous Peritoneal Metastases: The Phase III GASTRIPEC-I TrialBeate Rau, Hauke Lang, Alfred Koenigsrainer, et al.
Blood|June 17, 2020
Glucagon-like peptide 2 for intestinal stem cell and Paneth cell repair during graft-versus-host disease in mice and humansJohana Norona, Petya Apostolova, Dominik Schmidt, et al.
JCO Precision Oncology|September 11, 2020
Personalized Clinical Decision Making Through Implementation of a Molecular Tumor Board: A German Single-Center ExperienceRouven Hoefflin, Anna-Lena Geißler, Ralph Fritsch, et al.
Pageof 3